Thomas Shrader
Stock Analyst at BTIG
(4.32)
# 1,348
Out of 5,070 analysts
725
Total ratings
40%
Success rate
8.3%
Average return
Main Sectors:
Stocks Rated by Thomas Shrader
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALEC Alector | Maintained: Buy | $6 | $1.87 | +220.86% | 27 | Oct 14, 2026 | |
| STOK Stoke Therapeutics | Reiterated: Buy | $39 | $22.50 | +73.33% | 32 | Oct 12, 2026 | |
| GANX Gain Therapeutics | Reiterated: Buy | $5 | $1.41 | +254.61% | 31 | Oct 5, 2026 | |
| TLSA Tiziana Life Sciences | Reiterated: Buy | $7 | $1.09 | +542.20% | 3 | Oct 5, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Reiterated: Buy | $20 | $12.03 | +66.25% | 14 | Oct 1, 2026 | |
| IVVD Invivyd | Reiterated: Buy | $10 | $0.646 | +1,447.99% | 9 | Sep 29, 2026 | |
| NTHI NeOnc Technologies Holdings | Reiterated: Buy | $15 | $2.60 | +478.03% | 3 | Sep 28, 2026 | |
| ABOS Acumen Pharmaceuticals | Reiterated: Buy | $8 | $1.82 | +340.77% | 30 | Sep 16, 2026 | |
| NRXP NRx Pharmaceuticals | Reiterated: Buy | $10 | $2.70 | +270.37% | 16 | Sep 14, 2026 | |
| SER Serina Therapeutics | Reiterated: Buy | $8 | $1.82 | +339.56% | 3 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.24 | +183.02% | 9 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 | $28.24 | +123.09% | 13 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.40 | +233.33% | 8 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 → $37 | $22.09 | +67.50% | 9 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $4.48 | +257.54% | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $18.40 | +111.96% | 38 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $5.57 | +618.13% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $89 | $66.80 | +33.23% | 27 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $228.90 | - | 51 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $25 | $11.14 | +124.42% | 15 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $12.82 | +48.21% | 8 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $147 | $51.36 | +186.21% | 6 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.19 | +82.65% | 17 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.8998 | +900.22% | 33 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $11.42 | +40.11% | 28 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.69 | - | 32 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $200 | $8.66 | n/a | 7 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.99 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.43 | n/a | 14 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $0.0001 | n/a | 6 | Mar 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $0.968 | n/a | 16 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.42 | n/a | 5 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $63.30 | n/a | 20 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 → $15 | $8.87 | n/a | 10 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.83 | n/a | 5 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.52 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $216 | $8.06 | n/a | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $12 | $3.42 | n/a | 8 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.72 | n/a | 4 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $14.10 | n/a | 2 | Mar 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $23.52 | n/a | 4 | Mar 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $57 → $70 | $22.51 | n/a | 5 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $19.57 | n/a | 7 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.06 | n/a | 4 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $6.10 | n/a | 5 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $12.11 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.000001 | n/a | 3 | Jul 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 | $1.21 | n/a | 4 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.20 | n/a | 9 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.15 | n/a | 8 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.05 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $11.01 | n/a | 1 | Oct 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $39 | $7.48 | n/a | 12 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $26 | $6.57 | n/a | 4 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $12 | $28.23 | n/a | 4 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $40 | $13.50 | n/a | 5 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $76 | $45.59 | n/a | 3 | Oct 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.9982 | n/a | 17 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $130 | $10.12 | n/a | 7 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 | $0.001 | n/a | 1 | Jun 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $38 | $5.87 | n/a | 9 | Jun 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.2 → $11 | $2.34 | n/a | 4 | Dec 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $147.92 | n/a | 1 | Mar 23, 2015 |
Alector
Oct 14, 2026
Maintained: Buy
Price Target: $6
Current: $1.87
Upside: +220.86%
Stoke Therapeutics
Oct 12, 2026
Reiterated: Buy
Price Target: $39
Current: $22.50
Upside: +73.33%
Gain Therapeutics
Oct 5, 2026
Reiterated: Buy
Price Target: $5
Current: $1.41
Upside: +254.61%
Tiziana Life Sciences
Oct 5, 2026
Reiterated: Buy
Price Target: $7
Current: $1.09
Upside: +542.20%
Arcturus Therapeutics Holdings
Oct 1, 2026
Reiterated: Buy
Price Target: $20
Current: $12.03
Upside: +66.25%
Invivyd
Sep 29, 2026
Reiterated: Buy
Price Target: $10
Current: $0.646
Upside: +1,447.99%
NeOnc Technologies Holdings
Sep 28, 2026
Reiterated: Buy
Price Target: $15
Current: $2.60
Upside: +478.03%
Acumen Pharmaceuticals
Sep 16, 2026
Reiterated: Buy
Price Target: $8
Current: $1.82
Upside: +340.77%
NRx Pharmaceuticals
Sep 14, 2026
Reiterated: Buy
Price Target: $10
Current: $2.70
Upside: +270.37%
Serina Therapeutics
Sep 10, 2026
Reiterated: Buy
Price Target: $8
Current: $1.82
Upside: +339.56%
Sep 9, 2026
Reiterated: Buy
Price Target: $12
Current: $4.24
Upside: +183.02%
Aug 25, 2026
Reiterated: Buy
Price Target: $63
Current: $28.24
Upside: +123.09%
Aug 20, 2026
Reiterated: Buy
Price Target: $8
Current: $2.40
Upside: +233.33%
Aug 13, 2026
Rated: Buy
Price Target: $28 → $37
Current: $22.09
Upside: +67.50%
Aug 11, 2026
Reiterated: Buy
Price Target: $16
Current: $4.48
Upside: +257.54%
Aug 6, 2026
Reiterated: Buy
Price Target: $39
Current: $18.40
Upside: +111.96%
Aug 5, 2026
Reiterated: Buy
Price Target: $40
Current: $5.57
Upside: +618.13%
Jul 29, 2026
Reiterated: Buy
Price Target: $89
Current: $66.80
Upside: +33.23%
Jul 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $228.90
Upside: -
Jul 7, 2026
Reiterated: Buy
Price Target: $14 → $25
Current: $11.14
Upside: +124.42%
Jun 11, 2026
Reiterated: Buy
Price Target: $19
Current: $12.82
Upside: +48.21%
Mar 30, 2026
Reiterated: Buy
Price Target: $147
Current: $51.36
Upside: +186.21%
Mar 26, 2026
Reiterated: Buy
Price Target: $4
Current: $2.19
Upside: +82.65%
Mar 17, 2026
Reiterated: Buy
Price Target: $9
Current: $0.8998
Upside: +900.22%
Nov 17, 2025
Reiterated: Buy
Price Target: $16
Current: $11.42
Upside: +40.11%
Nov 3, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.69
Upside: -
Jul 21, 2025
Reiterated: Buy
Price Target: $8 → $200
Current: $8.66
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $2.99
Upside: n/a
Mar 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $6.43
Upside: n/a
Mar 19, 2024
Reiterated: Buy
Price Target: $32
Current: $0.0001
Upside: n/a
Feb 28, 2024
Reiterated: Buy
Price Target: $33
Current: $0.968
Upside: n/a
Jan 5, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.42
Upside: n/a
Nov 17, 2023
Rated: Hold
Price Target: n/a
Current: $63.30
Upside: n/a
Nov 14, 2023
Rated: Buy
Price Target: $32 → $15
Current: $8.87
Upside: n/a
Aug 4, 2023
Rated: Hold
Price Target: n/a
Current: $3.83
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $2.52
Upside: n/a
Apr 3, 2023
Reiterated: Buy
Price Target: $216
Current: $8.06
Upside: n/a
Mar 20, 2023
Rated: Buy
Price Target: $50 → $12
Current: $3.42
Upside: n/a
Mar 20, 2023
Reiterated: Hold
Price Target: n/a
Current: $4.72
Upside: n/a
Mar 12, 2023
Rated: Buy
Price Target: $20
Current: $14.10
Upside: n/a
Mar 5, 2023
Reiterated: Buy
Price Target: $56
Current: $23.52
Upside: n/a
Mar 2, 2023
Rated: Buy
Price Target: $57 → $70
Current: $22.51
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $19.57
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $1.06
Upside: n/a
Sep 9, 2021
Rated: Buy
Price Target: $16
Current: $6.10
Upside: n/a
Aug 6, 2021
Reiterated: Buy
Price Target: $60
Current: $12.11
Upside: n/a
Jul 6, 2021
Rated: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Jun 10, 2021
Reiterated: Buy
Price Target: $5.5
Current: $1.21
Upside: n/a
Jun 4, 2021
Rated: Hold
Price Target: n/a
Current: $1.20
Upside: n/a
May 10, 2021
Reiterated: Hold
Price Target: n/a
Current: $2.15
Upside: n/a
Sep 23, 2020
Downgraded: Hold
Price Target: n/a
Current: $1.05
Upside: n/a
Oct 6, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $11.01
Upside: n/a
Nov 9, 2017
Reiterated: Buy
Price Target: $57 → $39
Current: $7.48
Upside: n/a
Nov 7, 2017
Reiterated: Buy
Price Target: $32 → $26
Current: $6.57
Upside: n/a
Nov 1, 2017
Reiterated: Buy
Price Target: $14 → $12
Current: $28.23
Upside: n/a
Oct 17, 2017
Reiterated: Buy
Price Target: $20 → $40
Current: $13.50
Upside: n/a
Oct 10, 2017
Reiterated: Buy
Price Target: $35 → $76
Current: $45.59
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $11
Current: $0.9982
Upside: n/a
Oct 2, 2017
Rated: Buy
Price Target: $110 → $130
Current: $10.12
Upside: n/a
Jun 30, 2017
Downgraded: Hold
Price Target: $6
Current: $0.001
Upside: n/a
Jun 21, 2017
Reiterated: Buy
Price Target: $32 → $38
Current: $5.87
Upside: n/a
Dec 22, 2016
Reiterated: Hold
Price Target: $1.2 → $11
Current: $2.34
Upside: n/a
Mar 23, 2015
Downgraded: Hold
Price Target: n/a
Current: $147.92
Upside: n/a